89 related articles for article (PubMed ID: 6280629)
1. Hypotensive properties of benzodioxane derivatives structurally related to R 28935. Comparison of activity with some receptor affinities.
Timmermans PB; Slothorst-Grisdijk FP; van Kemenade JE; Schoop AM; Batink HD; van Zwieten PA
Arch Int Pharmacodyn Ther; 1982 Feb; 255(2):321-34. PubMed ID: 6280629
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of R 28935- and R 29814-induced hypotension by prazosin in anaesthetized normotensive rats.
Timmermans PB; Slothorst-Grisdijk FP; Kwa HY; van Zwieten PA
Arch Int Pharmacodyn Ther; 1982 Feb; 255(2):309-20. PubMed ID: 7073408
[TBL] [Abstract][Full Text] [Related]
3. A benzodioxanhydroxyethylpiperidine derivative with an acute central hypotensive action, different from that of clonidine. A comparison with neuroleptic agents.
Van Zwieten PA
Arch Int Pharmacodyn Ther; 1975 May; 215(1):104-18. PubMed ID: 1156040
[TBL] [Abstract][Full Text] [Related]
4. Selectivity of benzodioxane alpha-adrenoceptor antagonists for alpha 1- and alpha 2-adrenoceptors determined by binding affinity.
Timmermans PB; van Kemenade JE; Batink HD; van Zwieten PA
Pharmacology; 1983; 26(5):258-69. PubMed ID: 6134295
[TBL] [Abstract][Full Text] [Related]
5. [Comparative study of piperoxan and 2-(2-imidazolinyl)-1, 4-benzodioxane (170 150) on pre- and postsynaptic receptors in the rat].
Mouillé P; Dabiré H; Fournier B; Schmitt H
J Pharmacol; 1982; 13(3):389-97. PubMed ID: 6290793
[TBL] [Abstract][Full Text] [Related]
6. [Alpha-adrenoblocking activity of a newly synthesized derivative of 1,4-benzodioxane].
Staneva D; Spasov V; Ivanov D
Eksp Med Morfol; 1984; 23(2):87-91. PubMed ID: 6147242
[No Abstract] [Full Text] [Related]
7. Centrally induced impairment of the hypotensive effects of R 28935 and R 29814 by prazosin in anaesthetized cats.
Timmermans PB; Van Zwieten PA
Eur J Pharmacol; 1980 Feb; 61(4):385-8. PubMed ID: 7053064
[TBL] [Abstract][Full Text] [Related]
8. Unusual mechanism of hypotensive activity exerted by erytrho-1-(1-[2-(1,4-benzodioxan-2-yl)-2-OH-ET-a1-4-piperidyl)-2-benzimidazolinone (R 28935).
Wellens D; De Wilde A; van Bogaert A; van Bogaert PP; Wouters L; Reneman RS; Janssen PA
Arch Int Pharmacodyn Ther; 1975 May; 215(1):91-103. PubMed ID: 1156047
[TBL] [Abstract][Full Text] [Related]
9. Centrally induced hypotension unreleated to alpha-adrenergic stimulation.
Wellens S; Van Nueten JM; Janssen PA
Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):334-7. PubMed ID: 238482
[TBL] [Abstract][Full Text] [Related]
10. Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding.
Morrow AL; Creese I
Mol Pharmacol; 1986 Apr; 29(4):321-30. PubMed ID: 3010073
[TBL] [Abstract][Full Text] [Related]
11. Specific binding of threo 1-(1-[2-(1,4-benzodioxane-2-yl)-2-hydroxyethyl]4-piperidyl)-2-benzimidazolinone (R 29814), to rat brain membranes.
Timmermans PB; Harms YM; Batink HD; Van Zwieten PA
Neuropharmacology; 1982 Oct; 21(10):1039-43. PubMed ID: 7145033
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of [3H]clonidine binding to rat brain alpha-adrenoceptors by imidazolidines. Correlation of binding potency and hypotensive activity.
Bechtel WD; Mierau J; Timmermans PB
Arzneimittelforschung; 1985; 35(1A):428-31. PubMed ID: 2985095
[TBL] [Abstract][Full Text] [Related]
13. Characterization of alpha-adrenoceptors in rat and guinea pig tissues using radiolabeled agonists and antagonists.
Jarrott B; Summers RJ; Culvenor AJ; Louis WJ
Circ Res; 1980 Jun; 46(6 Pt 2):I15-20. PubMed ID: 6247087
[TBL] [Abstract][Full Text] [Related]
14. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
[TBL] [Abstract][Full Text] [Related]
15. Central hypotensive and antihypertensive activities of imidazolidines, structurally related to clonidine.
Timmermans PB; Van Zwieten PA
Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):251-67. PubMed ID: 921415
[TBL] [Abstract][Full Text] [Related]
16. Interaction between centrally acting hypotensive drugs and tricyclic antidepressants.
van Zwieten PA
Arch Int Pharmacodyn Ther; 1975 Mar; 214(1):12-30. PubMed ID: 1156022
[TBL] [Abstract][Full Text] [Related]
17. Hypotensive action of a new benzimidazolinone derivative, threo-1-(2-hydroxy-2-(3,4,5-trimethoxyphenyl)-1-methylethyl)-4-(1,3-dihydro-2H-benzimidazol-2-one-1-yl)piperidine (KF-4942): prazosin-like mode of action.
Karasawa A; Shuto K; Kubo K; Kasuya Y; Hashikami M; Shigenobu K
Arch Int Pharmacodyn Ther; 1983 Feb; 261(2):278-90. PubMed ID: 6132590
[TBL] [Abstract][Full Text] [Related]
18. Binding of (+/-)-3H-lofexidine to alpha-adrenoceptors in membranes from rat brain.
Timmermans PB; van Kemenade JE; Harms YM; Prop G; Graf E; van Zwieten PA
Arch Int Pharmacodyn Ther; 1983 Jan; 261(1):23-35. PubMed ID: 6303236
[TBL] [Abstract][Full Text] [Related]
19. [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.
Michel MC; Brodde OE; Schnepel B; Behrendt J; Tschada R; Motulsky HJ; Insel PA
Mol Pharmacol; 1989 Mar; 35(3):324-30. PubMed ID: 2564631
[TBL] [Abstract][Full Text] [Related]
20. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
Asano M; Hashimoto H; Nakashima M
Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
